HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas.

Abstract
Ductectatic-type mucinous cystic neoplasms of the pancreas constitute a recently recognized new human pancreatic tumor entity. Examination for the presence of point mutations at codon 12 of K-ras by oligonucleotide hybridization in 5 adenomas and 3 carcinomas revealed alteration in 3 and 2, respectively. In 4 of these positive cases, the transition was GGT----GAT (Gly----Asp) with the remaining one, found in a cancer, being GGT----GTT (Gly----Val). In two carcinoma cases, the same point mutation was detected both in the carcinoma area and in a coexisting adenoma component. Thus K-ras point mutation appears to be associated with this particular type of neoplasm in the same manner as observed for typical exocrine pancreas carcinomas. Our study also indicates the possible existence of an adenoma-carcinoma sequence in the evolution of this type of neoplasm and we suggest that K-ras activation may be an important event in the phase of adenoma development.
AuthorsA Yanagisawa, Y Kato, K Ohtake, T Kitagawa, K Ohashi, M Hori, K Takagi, H Sugano
JournalJapanese journal of cancer research : Gann (Jpn J Cancer Res) Vol. 82 Issue 10 Pg. 1057-60 (Oct 1991) ISSN: 0910-5050 [Print] Japan
PMID1955373 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Oligonucleotide Probes
  • Oligonucleotides
  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)
Topics
  • Adenoma (genetics, pathology)
  • Base Sequence
  • Cystadenoma (genetics, pathology)
  • Humans
  • Molecular Sequence Data
  • Mutation
  • Nucleic Acid Hybridization
  • Oligonucleotide Probes (chemistry)
  • Oligonucleotides (chemistry)
  • Pancreatic Neoplasms (genetics, pathology)
  • Polymerase Chain Reaction
  • Proto-Oncogene Proteins p21(ras) (genetics)
  • Proto-Oncogenes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: